<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02919709</url>
  </required_header>
  <id_info>
    <org_study_id>P/2013/186</org_study_id>
    <nct_id>NCT02919709</nct_id>
  </id_info>
  <brief_title>Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells</brief_title>
  <acronym>ANOPEC 3</acronym>
  <official_title>Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the existence of a reliable correlation between the progression
      of aortic diameters and blood levels of circulant endothelial progenitor cells CD34+ in
      patients with not surgical aortic aneurysms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>progenitor cells CD34+ blood levels</measure>
    <time_frame>At diagnosis of aneurysm</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>progenitor cells CD34+ blood levels</measure>
    <time_frame>6 month after disgnosis</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>progenitor cells CD34+ blood levels</measure>
    <time_frame>12 month after diagnosis</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>progenitor cells CD34+ blood levels</measure>
    <time_frame>18 month after diagnosis</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>progenitor cells CD34+ blood levels</measure>
    <time_frame>24 month after diagnosis</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment</condition>
  <arm_group>
    <arm_group_label>thoracic or abdominal aortic aneurysm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood taking</intervention_name>
    <arm_group_label>thoracic or abdominal aortic aneurysm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients aged 18 or more.

          2. Patients diagnosed with a thoracic or abdominal aortic aneurysm with no indication for
             surgical treatment (diameters &gt; 30 mm but &lt; 50 mm).

          3. Patients accepting to sign a specific informed consent.

        Exclusion Criteria:

          1. Unstable coronary artery disease.

          2. Congenital heart disease.

          3. Any evolving infectious syndrome or viral infection (HIV, HBV or HCV).

          4. Any chronic inflammatory or autoimmune disease.

          5. Prior administration of G-CSF; EPO; GM-CSF.

          6. Liver failure.

          7. Prior oncologic disease or ongoing cancer with a life expectancy &lt; 1 year.

          8. Dementia.

          9. Pregnancy.

         10. Patients aged &lt; 18.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrea PERROTTI, MD</last_name>
    <email>aperrotti@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andréa PERROTTI, MD</last_name>
      <email>aperrotti@chu-besancon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2016</study_first_posted>
  <last_update_submitted>September 27, 2016</last_update_submitted>
  <last_update_submitted_qc>September 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

